Poesen Koen, Lambrechts Diether, Van Damme Philip, Dhondt Joke, Bender Florian, Frank Nicolas, Bogaert Elke, Claes Bart, Heylen Line, Verheyen An, Raes Katrien, Tjwa Marc, Eriksson Ulf, Shibuya Masabumi, Nuydens Rony, Van Den Bosch Ludo, Meert Theo, D'Hooge Rudi, Sendtner Michael, Robberecht Wim, Carmeliet Peter
Vesalius Research Center, Katholieke Universiteit Leuven, Leuven B-3000, Belgium.
J Neurosci. 2008 Oct 15;28(42):10451-9. doi: 10.1523/JNEUROSCI.1092-08.2008.
Although vascular endothelial growth factor-B (VEGF-B) is a homolog of the angiogenic factor VEGF, it has only minimal angiogenic activity, raising the question of whether this factor has other (more relevant) biological properties. Intrigued by the possibility that VEGF family members affect neuronal cells, we explored whether VEGF-B might have a role in the nervous system. Here, we document that the 60 kDa VEGF-B isoform, VEGF-B(186), is a neuroprotective factor. VEGF-B(186) protected cultured primary motor neurons against degeneration. Mice lacking VEGF-B also developed a more severe form of motor neuron degeneration when intercrossed with mutant SOD1 mice. The in vitro and in vivo effects of VEGF-B(186) were dependent on the tyrosine kinase activities of its receptor, Flt1, in motor neurons. When delivered intracerebroventricularly, VEGF-B(186) prolonged the survival of mutant SOD1 rats. Compared with a similar dose of VEGF, VEGF-B(186) was safer and did not cause vessel growth or blood-brain barrier leakiness. The neuroprotective activity of VEGF-B, in combination with its negligible angiogenic/permeability activity, offers attractive opportunities for the treatment of neurodegenerative diseases.
尽管血管内皮生长因子-B(VEGF-B)是血管生成因子VEGF的同源物,但其血管生成活性极小,这就引发了该因子是否具有其他(更相关的)生物学特性的问题。鉴于VEGF家族成员可能影响神经元细胞,我们探究了VEGF-B是否在神经系统中发挥作用。在此,我们证明60 kDa的VEGF-B同工型VEGF-B(186)是一种神经保护因子。VEGF-B(186)可保护原代培养的运动神经元免于退化。与突变型SOD1小鼠杂交时,缺乏VEGF-B的小鼠也会发生更严重形式的运动神经元退化。VEGF-B(186)的体外和体内作用依赖于其受体Flt1在运动神经元中的酪氨酸激酶活性。当经脑室内给药时,VEGF-B(186)可延长突变型SOD1大鼠的存活时间。与相同剂量的VEGF相比,VEGF-B(186)更安全,不会引起血管生长或血脑屏障渗漏。VEGF-B的神经保护活性及其可忽略不计的血管生成/通透性活性,为神经退行性疾病的治疗提供了有吸引力的机会。